NEW DRUG PRODUCT: DAYVIGO

FEATURED
Find out more about Dayvigo including dosing and important safety information with our slideshow, complete drug monograph, and downloadable PDF.

DRUGS IN THE PIPELINE

Cefiderocol Gets Priority Review for Nosocomial Pneumonia Upadacitinib Application for Active Psoriatic Arthritis Submitted for Review Phase 3 Trial Evaluating Roluperidone in Schizophrenia Misses End Points Clinical Remission Observed With Ozanimod in Ulcerative Colitis Trial Antigen-Specific Therapy for Anti-MAG Neuropathy Gets Orphan Drug Status

The right dose of information. eMPR.com

RRMS: Key Clinical and Patient Considerations AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists

CME/CE Spotlight